INTERNATIONAL PATENT: TENEOONE, INC. FILES APPLICATION FOR "TREATING MULTIPLE MYELOMA WITH ANTI-CD3/BCMA BISPECIFIC ANTIBODY IN COMBINATION WITH AN ANTI-CD38 ANTIBODY"

GENEVA, Feb. 11 -- TENEOONE, INC. (1 North Waukegan RoadNorth Chicago, IL 60064) filed a patent application (PCT/US2025/040042) for "TREATING MULTIPLE MYELOMA WITH ANTI-CD3/BCMA BISPECIFIC ANTIBODY IN COMBINATION WITH AN ANTI-CD38 ANTIBODY" on Jul 31, 2025. With publication no. WO/2026/030537, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FLEMING, Leanne, Lash (1 North Waukegan RoadNorth Chicago, IL 60064), SVENSSON, Anders (1 North Waukegan RoadNorth Chicago, IL 60064)

Abstract: Methods of treating relapsed or refract...